Welcome to the DZIF -
the German Center for Infection Research

Gastrointestinal Infections

Hepatitis

HIV

Infections of the Immunocompromised Host

Healthcare-Associated and Antibiotic-Resistant Bacterial Infections

Malaria and Neglected Tropical Diseases

Emerging Infections

Novel Antibiotics

Tuberculosis

Portrait of Dr. Janko Sattler. Mr Sattler is wearing a dark suit and tie.

Sep 20 2023

Research award for DZIF Scientist Janko Sattler

Sep 15 2023

Successfully promoting new approaches to antibacterial therapies: INCATE celebrates its two-year anniversary

The INCubator for Antibacterial Therapies in Europe, INCATE, can point to an impressive series of successes on its two-year anniversary. With direct contact to more than 180 start-ups and initiatives

Prof. Marylyn (left) receiving the Cross of the Order of Merit of the Federal Republic of Germany in Hamburg. Science Senator Katharina Fegebank is standing to her right.

Aug 26 2023

Professor Marylyn Addo receives the Cross of the Order of Merit of the Federal Republic of Germany

Prof. Marylyn Addo was awarded the Cross of the Order of Merit of the Federal Republic of Germany on August 25, 2023. She received the honour for her outstanding medical and scientific achievements in

The photo shows a group of four researchers (three women and one man) in white lab coats in a laboratory.

Aug 22 2023

Researchers decode new antibiotic agent

More and more bacterial pathogens are developing resistance. There is an increasing risk that current drugs will no longer be effective against infectious diseases. Scientists around the world are

Prof. Rolf Müller (left in the picture) during the award ceremony of the Charles Thom Award in Minneapolis.

Aug 8 2023

Charles Thom Award 2023 for Rolf Müller

Prof. Rolf Müller, the Founding and Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, has

All news

The DZIF at a glance:

United against infections

Learn more about the German Center for Infection Research (DZIF) and the four grand infectious disease challenges of our time:

DZIF portrait page

GIF animation of grand challenges, research areas and infrastructures within DZIF

pdf (3.1 MB)

DZIF Annual Report 2022

pdf (3.1 MB)

Video

Das zentrale Bioprobenregister im DZIF

Video

pdf (3.65 MB)

DZIF Annual Report 2021

pdf (3.65 MB)

Find Media Content

Hannover - Braunschweig | Heidelberg | München | Tübingen

Transplant Cohort

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s susceptibility to infection and organ function. In [...]

Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Centre

The Clinical Tuberculosis Centre provides the expertise and infrastructure for the optimisation, prevention, diagnosis and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Centre include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Hannover - Braunschweig

Preclinical development of Amidochelocardins

The challenge of antibiotic drug development today is the discovery and optimisation of novel bioactive compounds that do not show cross-resistances with clinically applied antibiotics, ideally due to a novel mode of action (MoA) which adresses unexploited microbial targets. In the case of chelocardin, this antibiotic substance was identified several [...]

Tübingen

New strategies for specific eradication of Staphylococcus aureus

In this project, the scientists develop genetically engineered phage lysins and specific bacteriocins for the elimination of hospital germs such as Staphylococcus aureus, they clarify mechanisms of potential resistance mechanisms, and they analyse whether broad-spectrum or specifically acting agents have a more effective and lasting effect on colonization by [...]